Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin vs trimethoprim/sulfamethoxazole for transrectal prostate biopsy prophylaxis
2014-002999-83Phase 4Terminated
- Sponsor
- Johan Styrke
- Start
- Dec 2014
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in bacterial disease, urinary tract infection (UTI) and bacterial prostatitis comparing Ciprofloxacin prophylaxis with Trimethoprim/sulfamethoxazole prophylaxis (2 arms). Primary endpoint: Subscribed urinary tract antibiotics within 2 weeks following prostate biopsy. Started Dec 2014; status: terminated.
02
Drugs
ciprofloxacintrimethoprim + sulfamethoxazole
03
Conditions
bacterial diseaseurinary tract infection (UTI)bacterial prostatitis
Beyond the preview
Go deeper on 2014-002999-83.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002999-83.